Literature DB >> 6726302

Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data.

T Han, M Barcos, L Emrich, H Ozer, R Gajera, G A Gomez, P A Reese, J Minowada, M L Bloom, N Sadamori.   

Abstract

Bone marrow biopsies were prospectively performed on 75 patients with chronic lymphocytic leukemia (CLL). There was a highly significant relationship (p less than 0.002) between clinical stages and bone marrow infiltration patterns. Ten (50%) of 20 patients with diffuse patterns died; the estimated median survival time for these patients was 87 months. In contrast, only six (11%) of 55 patients with nondiffuse patterns died; the estimated median survival time for these patients could not be computed. When both clinical stage and infiltration pattern were evaluated for survival, a highly significant association between clinical stage and survival time was still observed (p less than 0.003) whereas bone marrow infiltration pattern was no longer significant. A significant association was also observed between bone marrow infiltration patterns and absolute lymphocyte counts (p less than 0.0005), Fc-receptor-positive cells (p less than 0.002), 3H-thymidine uptake of leukocytes (p less than 0.01), serum alkaline phosphatase levels (p less than 0.05), monoclonal urinary-free light chain status (p less than 0.05), and cytogenetics of leukemic cells (p less than 0.05). These observations lead to the conclusion that in an overall prognostic evaluation of patients with CLL, although bone marrow histopathology may have no additional value over a well-established clinical staging system, as a whole, it may be of clinically predictive value in disease progression of patients with stage I and II.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6726302     DOI: 10.1200/JCO.1984.2.6.562

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  11 in total

1.  Reticulin fibre content of bone marrow infiltrates of malignant non-Hodgkin's lymphomas (B-cell type, low malignancy)--a morphometric evaluation before and after therapy.

Authors:  J Thiele; J Langohr; M Skorupka; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib.

Authors:  Davorka Messmer; Jessie-F Fecteau; Morgan O'Hayre; Ila S Bharati; Tracy M Handel; Thomas J Kipps
Journal:  Blood       Date:  2010-11-15       Impact factor: 22.113

3.  Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.

Authors:  Kumudha Balakrishnan; Jan A Burger; Maite P Quiroga; Marina Henneberg; Mary L Ayres; William G Wierda; Varsha Gandhi
Journal:  Blood       Date:  2010-05-04       Impact factor: 22.113

4.  An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease.

Authors:  Paolo Giannoni; Silvia Scaglione; Rodolfo Quarto; Roberto Narcisi; Manuela Parodi; Enrico Balleari; Federica Barbieri; Alessandra Pattarozzi; Tullio Florio; Silvano Ferrini; Giorgio Corte; Daniela de Totero
Journal:  Haematologica       Date:  2011-04-12       Impact factor: 9.941

5.  Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma--a practical guideline.

Authors:  J Thiele; T K Zirbes; H M Kvasnicka; R Fischer
Journal:  J Clin Pathol       Date:  1999-04       Impact factor: 3.411

Review 6.  Prognostic factors in chronic lymphocytic leukemia-what do we need to know?

Authors:  Paula Cramer; Michael Hallek
Journal:  Nat Rev Clin Oncol       Date:  2010-10-19       Impact factor: 66.675

7.  Immuno-phenotype and proliferative response of B-cell chronic lymphocytic leukemia.

Authors:  S Karfa; R Gopal; J S Nadkarni
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

8.  Impact of oxygen concentration on growth of mesenchymal stromal cells from the marrow of patients with chronic lymphocytic leukemia.

Authors:  Jessie-F Fecteau; Davorka Messmer; Suping Zhang; Bing Cui; Liguang Chen; Thomas J Kipps
Journal:  Blood       Date:  2012-12-18       Impact factor: 22.113

9.  Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.

Authors:  Antonina V Kurtova; Kumudha Balakrishnan; Rong Chen; Wei Ding; Susanne Schnabl; Maite P Quiroga; Mariela Sivina; William G Wierda; Zeev Estrov; Michael J Keating; Medhat Shehata; Ulrich Jäger; Varsha Gandhi; Neil E Kay; William Plunkett; Jan A Burger
Journal:  Blood       Date:  2009-09-17       Impact factor: 22.113

10.  Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

Authors:  Nina Kreuzberger; Johanna Aag Damen; Marialena Trivella; Lise J Estcourt; Angela Aldin; Lisa Umlauff; Maria Dla Vazquez-Montes; Robert Wolff; Karel Gm Moons; Ina Monsef; Farid Foroutan; Karl-Anton Kreuzer; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.